false 0001576280 0001576280 2024-06-12 2024-06-12

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): June 12, 2024

 

 

GUARDANT HEALTH, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-38683   45-4139254

(State or other jurisdiction of

incorporation or organization)

   (Commission
File Number)		   (IRS Employer
Identification No.)

3100 Hanover Street

Palo Alto, California 94304

(Address of principal executive offices) (Zip Code)

855-698-8887

(Registrant’s telephone number, include area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

  

Trading
Symbol(s)

  

Name of each exchange
on which registered

Common Stock, $0.00001 par value per share   GH   The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 5.07. Submission of Matters to a Vote of Security Holders.

The annual meeting of stockholders (the “Annual Meeting”) of Guardant Health, Inc. (the “Company”) was held on June 12, 2024.

All of the nominees for director listed in Proposal 1 in the Company’s Definitive Proxy Statement on Schedule 14A, as filed with the Securities and Exchange Commission on April 25, 2024 (the “Proxy Statement”), were elected to serve on the Company’s board of directors by the following vote:

 

Name of Nominee    Votes For    Votes
Withheld		    Broker
Non-Votes

Helmy Eltoukhy

    89,595,582    1,407,958    6,193,090

Steve Krognes

    64,412,704    25,590,836    6,193,090

AmirAli Talasaz

    90,503,626    499,914    6,193,090

Proposal 2 in the Proxy Statement, a proposal to ratify the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2024, was approved by the following vote:

 

Votes For

  

Votes Against

  

Abstentions

96,479,592   676,160   40,878

Proposal 3 in the Proxy Statement, a proposal to approve, on an advisory (non-binding) basis, the compensation of the Company’s named executive officers, was not approved by the following vote:

 

Votes For

  

Votes Against

  

Abstentions

  

Broker

Non-Votes

84,585,946   5,812,828   604,766   6,193,090

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    GUARDANT HEALTH, INC.
Date: June 14, 2024     By:  

/s/ John G. Saia

      John G. Saia
      Chief Legal Officer and Corporate Secretary
v3.24.1.1.u2
Document and Entity Information
Jun. 12, 2024
Cover [Abstract]  
Amendment Flag false
Entity Central Index Key 0001576280
Document Type 8-K
Document Period End Date Jun. 12, 2024
Entity Registrant Name GUARDANT HEALTH, INC.
Entity Incorporation State Country Code DE
Entity File Number 001-38683
Entity Tax Identification Number 45-4139254
Entity Address, Address Line One 3100 Hanover Street
Entity Address, City or Town Palo Alto
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94304
City Area Code 855
Local Phone Number 698-8887
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, $0.00001 par value per share
Trading Symbol GH
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Guardant Health (NASDAQ:GH)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Guardant Health Charts.
Guardant Health (NASDAQ:GH)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Guardant Health Charts.